NewGenIvf director reports no current shareholdings

NewGenIvf says its Form 3 was filed late for Lam Chun Tung Patrick due to notarization and EDGAR access delays, and it reports no holdings or transactions yet.

Rhea-AI Filing Summary

NewGenIvf Group Ltd (NIVF) filed an initial ownership report on Form 3 for Lam Chun Tung Patrick, who serves as an Independent Non-Executive Director. The filing states there are no reportable holdings or transactions in NewGenIvf Group Ltd securities at this time. The company explains the Form 3 was submitted late due to administrative and logistical delays in obtaining remote/foreign notarization and EDGAR access credentials for the newly appointed director, who was appointed on June 8, 2026.

Key Figures

Transactions reported: 0 transactions Shares bought: 0 shares Shares sold: 0 shares +1 more

4 metrics

Transactions reported 0 transactions No buys, sells, acquisitions, dispositions, or other transactions reported on the Form 3

Shares bought 0 shares No purchase transactions reported for NewGenIvf Group Ltd securities

Shares sold 0 shares No sale transactions reported for NewGenIvf Group Ltd securities

Appointment date June 8, 2026 Date Lam Chun Tung Patrick was appointed as an Independent Non-Executive Director

Key Terms

Independent Non-Executive Director, Form 3, EDGAR access credentials, remote/foreign notarization

4 terms

Independent Non-Executive Director financial

"The Reporting Person was appointed as an Independent Non-Executive Director on June 8, 2026"

An independent non-executive director is a board member who is not part of a company’s day-to-day management and has no close ties to major owners, so they can offer unbiased oversight of strategy, risks, and executive pay. For investors, they act like an impartial referee who helps prevent conflicts of interest, improve transparency and hold management accountable, which can reduce governance risk and protect shareholder value.

Form 3 regulatory

"This Form 3 is being filed late due to administrative and logistical delays"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

EDGAR access credentials regulatory

"processing the initial EDGAR access credentials (Form ID) for the newly appointed Reporting Person"

remote/foreign notarization regulatory

"delays within the Company in securing the necessary remote/foreign notarization"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for NIVF disclose about Lam Chun Tung Patrick?

It discloses that Lam Chun Tung Patrick, an Independent Non-Executive Director of NewGenIvf Group Ltd, has filed an initial Form 3 and currently has no reportable holdings or transactions in the company’s securities.

Does the NIVF Form 3 show any insider buying or selling?

No. The Form 3 for NewGenIvf Group Ltd reports no transactions: buy, sell, acquire, dispose, or other all register as zero, and there are no derivative positions reported.

Why was the NewGenIvf Group Ltd (NIVF) Form 3 filed late?

The company states the Form 3 was filed late due to administrative and logistical delays in securing remote/foreign notarization and processing the EDGAR access credentials (Form ID) for the newly appointed reporting person.

What position does the reporting person hold at NewGenIvf Group Ltd (NIVF)?

The reporting person, Lam Chun Tung Patrick, is identified as an Independent Non-Executive Director of NewGenIvf Group Ltd. He is not listed as an officer and not as a ten percent owner in this filing.

When was Lam Chun Tung Patrick appointed at NIVF?

NewGenIvf Group Ltd reports that Lam Chun Tung Patrick was appointed as an Independent Non-Executive Director on June 8, 2026, and the Form 3 reflects his status as of that appointment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 08:03 AM EDT Accepted by SEC EDGAR 09/02/2026 - 08:03 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lam Chun Tung Patrick

(Last) (First) (Middle)

ROOM 2009, YIU FOOK HSE, YIU TUNG ESTATE

SHAUKEIWAN, HONG KONG

(Street)

HONG KONG 00000

(City) (State) (Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/08/2026

3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is being filed late due to administrative and logistical delays within the Company in securing the necessary remote/foreign notarization and processing the initial EDGAR access credentials (Form ID) for the newly appointed Reporting Person. The Reporting Person was appointed as an Independent Non-Executive Director on June 8, 2026.

No securities are beneficially owned.

	/s/ Lam Chun Tung Patrick	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)